
1. Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity. *Cell Metab*. 2015;21(3):443–454. doi:10.1016/j.cmet.2015.02.009
2. Reynolds JC, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. *Nat Commun*. 2021;12(1):470. doi:10.1038/s41467-020-20790-0
3. Kim KH, et al. MOTS-c: a novel mitochondrial-derived peptide regulating muscle and metabolic homeostasis. *Free Radic Biol Med*. 2018;100:182–187. doi:10.1016/j.freeradbiomed.2016.04.023
4. Zarse K, et al. Mitochondrial peptides as mediators of inter-organelle signaling: role of MOTS-c. *Aging Cell*. 2019;18(2):e12845. doi:10.1111/acel.12845
5. Lu H, et al. MOTS-c prevents diet-induced obesity and insulin resistance in mice. *Aging (Albany NY)*. 2018;10(11): 1–12. doi:10.18632/aging.101630
6. Yong C, et al. MOTS-c improves insulin resistance by activating AMPK and enhancing glucose uptake. *Biochem Biophys Res Commun*. 2016;473(2):425–431. doi:10.1016/j.bbrc.2016.03.109
7. Ramanjaneya M, et al. Circulating MOTS-c levels in aging and metabolic disease. *Clin Endocrinol (Oxf)*. 2019;91(5):697–705. doi:10.1111/cen.14089
8. Miller B, et al. MOTS-c enhances exercise performance and muscle metabolism. *J Cachexia Sarcopenia Muscle*. 2021;12(6):1642–1656. doi:10.1002/jcsm.12748
9. Zhao Y, et al. MOTS-c as a potential therapeutic peptide for age-related disease. *Front Endocrinol (Lausanne)*. 2019;10:438. doi:10.3389/fendo.2019.00438
10. Du C, et al. MOTS-c as a regulator of mitochondrial signaling and metabolic adaptation. *Trends Endocrinol Metab*. 2022;33(1):25–37. doi:10.1016/j.tem.2021.10.001
2. Reynolds JC, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. *Nat Commun*. 2021;12(1):470. doi:10.1038/s41467-020-20790-0
3. Kim KH, et al. MOTS-c: a novel mitochondrial-derived peptide regulating muscle and metabolic homeostasis. *Free Radic Biol Med*. 2018;100:182–187. doi:10.1016/j.freeradbiomed.2016.04.023
4. Zarse K, et al. Mitochondrial peptides as mediators of inter-organelle signaling: role of MOTS-c. *Aging Cell*. 2019;18(2):e12845. doi:10.1111/acel.12845
5. Lu H, et al. MOTS-c prevents diet-induced obesity and insulin resistance in mice. *Aging (Albany NY)*. 2018;10(11): 1–12. doi:10.18632/aging.101630
6. Yong C, et al. MOTS-c improves insulin resistance by activating AMPK and enhancing glucose uptake. *Biochem Biophys Res Commun*. 2016;473(2):425–431. doi:10.1016/j.bbrc.2016.03.109
7. Ramanjaneya M, et al. Circulating MOTS-c levels in aging and metabolic disease. *Clin Endocrinol (Oxf)*. 2019;91(5):697–705. doi:10.1111/cen.14089
8. Miller B, et al. MOTS-c enhances exercise performance and muscle metabolism. *J Cachexia Sarcopenia Muscle*. 2021;12(6):1642–1656. doi:10.1002/jcsm.12748
9. Zhao Y, et al. MOTS-c as a potential therapeutic peptide for age-related disease. *Front Endocrinol (Lausanne)*. 2019;10:438. doi:10.3389/fendo.2019.00438
10. Du C, et al. MOTS-c as a regulator of mitochondrial signaling and metabolic adaptation. *Trends Endocrinol Metab*. 2022;33(1):25–37. doi:10.1016/j.tem.2021.10.001